Bioprocess Controllers and Automation Systems Market, 2021-2030

 

To order this 230+ page report, please visit www.rootsanalysis.com/reports/bioprocess-controllers-and-automation-systems-market.html    

 

Key Inclusions

§  A detailed assessment of the overall market landscape of bioprocess controller and automation systems (upstream controllers, downstream controller systems and bioprocess control software) based on a number of relevant parameters, such as scale of operation (lab, clinical and commercial), mode of operation (batch, fed-batch and perfusion), key features (scalability / ease to use, visual data display, remote accessibility, data processing capabilities, built-in system control sensors, expansive I/O compatibility and provisions for alarms / alerts), compatibility with the bioprocessing systems (stirred tank (glass), single use bioreactor, stirred tank (steel), fermenter, rocking motion, chromatography system, tangential flow filtration system), type of system(s) (single-use system and multi-use system) and type of processes controlled (cell cultivation, microbial fermentation, chromatography and filtration). In addition, it presents details of the companies manufacturing bioprocess controller and automation systems, highlighting their year of establishment, company size, and geographical presence.

§  A detailed competitiveness analysis of upstream controllers, downstream controller systems and process control software, taking into consideration several relevant parameters, such as the application strength (scale of operation, processes controlled, mode of operation and stage of bioprocess) and product strength (key features, and compatibility with system).

§  Tabulated profiles of the key players providing upstream controllers, downstream controller systems and process control software, which are headquartered in North America and Europe. Each profile includes an overview of the company, information on the financial performance (if available), product portfolio, recent developments, and an informed future outlook.

§  A contemporary market trend analysis, featuring a world map representation to highlight the regional distribution of players engaged in the development of upstream controllers, downstream controller systems and bioprocess control software, along with the information on type of products offered (upstream controllers, downstream controller systems and bioprocess control software). Further, the chapter also presents (a) a heat map representation of upstream controllers, based on compatibility with bioreactor systems, scale of operation and mode of operation, (b) a grid analysis of upstream controllers, based on scale of operation, compatibility with bioreactor systems and processes controlled (c) a grid analysis of downstream controller systems, based on scale of operation, type of systems and key features, (d) an analysis of downstream controller systems, based on mode of operation and application area (e) a grid analysis of bioprocess control software, based on  scale of operation, key features and processes controlled and (f) an analysis of bioprocess control software, based on scale of operation and compatibility with bioprocessing systems.

§  An in-depth analysis of various patents that have been filed / granted for bioprocess controller and automation systems, till July 2021, highlighting key trends associated with these patents, across type of patents, publication year, application year, issuing authorities involved, type of organizations, emerging focus area, patent age, CPC symbols, leading patent assignees (in terms of number of patents granted / filed), patent characteristics and geography. It also includes a detailed patent benchmarking and an insightful valuation analysis.

§  A detailed brand positioning analysis of the key industry players (including upstream controller developers, downstream controller system developers, and bioprocess control software developers), highlighting the current perceptions regarding their proprietary products by taking into consideration several relevant aspects, such as experience of the manufacturer, number of products offered, product diversity, and number of patents published.

 

The report features the likely distribution of the current and forecasted opportunity across important antibody purification services market segments, mentioned below:

 

§  Type of Controllers

  • Upstream / Downstream controller systems
  • Bioprocess control software

 

§  Analysis by Scale of Operation

  • Preclinical / Clinical Operation
  • Commercial Operation

 

§  Analysis by Mode of Operation

§  Batch / Fed-batch

§  Perfusion

 

§  Analysis by Types of Systems

§  Single-use systems

§  Stainless Steel / Other Systems

 

§  Analysis by Geographical Regions

  • North America
  • Europe
  • Asia Pacific and Rest of the World

 

The report also features inputs from eminent industry stakeholders, according to whom, the several bioprocessing companies are likely to adopt bioprocess controllers and automation systems in the foreseen future. The report includes detailed transcripts of discussion held with prominent industry representatives.

 

To request sample pages, please visit https://www.rootsanalysis.com/reports/bioprocess-controllers-and-automation-systems-market.html

                                                                                               

Key Questions Answered

§  Who are the leading players engaged in the development of bioprocess controller and automation systems?

§  What are the different application areas where bioprocess controller and automation systems can be used?

§  What are the key features of bioprocess controller and automation systems?

§  How has the intellectual property landscape of bioprocess controller and automation, evolved over the years?

§  What are the key trends within the bioprocess controllers and automation systems market?

§  How is the current and future opportunity likely to be distributed across key market segments?

 

You may also be interested in the following titles: 

1.     Continuous Manufacturing Equipment Providers Market: Industry Trends and Global Forecast, 2021-2030

2.     Single-Use Bioreactors Market (2nd Edition):  Industry Trends and Global Forecast, 2021-2030

3.     Telemedicine Tools and Software Providers Market: Industry Trends and Global Forecasts, 2021-2030

4.     Cloud-based Solutions for Drug Discovery, Development and Manufacturing Market: Industry Trends and Global Forecast, 2021-2030

 

Contact Details

Ben Johnson

+1 (415) 800 3415

ben.johnson@rootsanalysis.com

 

Roots Analysis

Web: https://www.rootsanalysis.com/

LinkedIn: https://in.linkedin.com/company/roots-analysis

Twitter: https://medium.com/@RootsAnalysis

Medium: https://medium.com/@RootsAnalysis

Pinterest: https://in.pinterest.com/RootsanalysisPin/_saved/

Quora: https://rootsanalysisinsights.quora.com/

Comments

Post a Comment

Popular posts from this blog

The microbial contract biomanufacturing market is growing at a CAGR of 8.7%, claims {Roots Analysis}

    The growing pipeline of biologics that can be produced in microbial systems, such as antibody fragments and plasmid-based therapies, is anticipated to offer lucrative opportunities to service providers serving this niche, but growing market segment     London   Roots Analysis has announced the addition of the “ Microbial Contract Biomanufacturing Market, 2020-2030 ” report to its list of offerings.   Despite mammalian cell cultures being the preferred manufacturing approach for biologics, recent advances in microbial fermentation have enabled the development of versatile biomanufacturing systems, which are both robust and cost friendly. Presently, a number of service provider companies claim to offer end-to-end solutions, ranging from product development to commercial production, for microbial biologics. Given the obvious advantages of outsourcing, drug developers are likely to continue relying on contract service providers for various...
Read more

Manufacturing Market Continuous (Small Molecules and Biologics), 2020 – 2030 by Roots Analysis

  Recent advances in the manufacturing technologies have prompted pharmaceutical companies to consider shifting from the traditional multi-step, batch manufacturing processes to faster, and relatively more efficient continuous manufacturing   Roots Analysis is pleased to announce the publication of its recent study, titled, “ Manufacturing Market Continuous (Small Molecules and Biologics), 2020 – 2030 .”   The report features an extensive study of the current market landscape and future opportunities for companies with capabilities in continuous manufacturing (both innovator companies with in-house expertise and contract manufacturers). It features an in-depth analysis, highlighting the capabilities of various stakeholders engaged in this domain. In addition to other elements, the study includes: §   A detailed assessment of the overall landscape of companies with capabilities for continuous manufacturing §   Elaborate profiles of some of the key...
Read more

A relatively larger proportion of these firms are headquartered in the US, claims Roots Analysis

  Lately, drug manufacturers have started showing evident interest in modular facilities and using modularity in design approaches owing to the amplified value of smaller production facilities, which are more efficient and flexible. The increased demand for multi-product, multi-purpose, smaller batch size facilities has also prompted equipment manufacturers to revisit their product offerings.   To order this 300+ page report, which features 120+ figures and 130+ tables, please visit this - https://www.rootsanalysis.com/reports/view_document/modular-facilities-flexible-drug-manufacturing-platforms-of-the-future/178.html   The USD xx billion (by 2030) financial opportunity within the modular facilities market has been analyzed across the following segments: ·        Type of Modular Construct  §   Hybrid Skid §   Plug-and-Play §   Skid-Mounted §   Truckable §   Others §   Type of Construc...
Read more